Main Article Content

Abstract

Neonatal sepsis is a burden around the world and causes high mortality and morbidity as well. Long-term neurodevelopmental disability may occur in survivors. General physicians, pediatricians, and neonatologists need be attentive to the proper diagnosis, starting, de-escalating or stopping empirical antimicrobials therapy in neonatal sepsis. Furthermore, multidrug resistant organisms have emerged among adults, children, and neonates in developing countries. Local epidemiology studies and antimicrobial stewardship programs are important for application of the best and specific treatments. Knowledge, definitions, and clinical practice of neonatal sepsis are updated in this review.

Keywords

Cross infections neonatal sepsis newborn vertical infectious disease transmission

Article Details

How to Cite
Thatrimontrichai, A. (2018). Review article: Neonatal Sepsis in Thailand. Folia Medica Indonesiana, 54(4), 306–310. https://doi.org/10.20473/fmi.v54i4.10719

References

  1. Austin N, Cleminson J, Darlow BA, et al (2015). Pro-phylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants. Cochrane Database Syst Rev, 10.1002/ 14651858.CD003478.pub5. Available from http://on-linelibrary.wiley.com/doi/10.1002/14651858.CD003478.pub5/full. doi:10.1002/14651858.CD003478.pub5
  2. Bharwani SK, Green BF, Pezzullo JC, et al (2016). Systematic review and meta-analysis of human milk intake and retinopathy of prematurity: a significant update. J Perinatol 36, 913-920
  3. Chusri S, Tuanyok A (2018). Antimicrobial Resistance: Genetic Perspectives and Implications. J Health Sci Med Res 36, 311-322
  4. Cleminson J, Austin N, McGuire W. (2015). Prophy-lactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants. Cochrane Database Syst Rev, 10.1002/14651858. CD003850.pub5. Available from http://onlinelibrary. wiley.com/doi/10.1002/14651858.CD003850.pub5/full doi:10.1002/14651858.CD003850.pub5
  5. Deshpande G, Jape G, Rao S, et al (2017). Benefits of probiotics in preterm neonates in low-income and medium-income countries: a systematic review of randomised controlled trials. BMJ Open 7, e017638
  6. Edmond KM, Kortsalioudaki C, Scott S, et al (2012). Group B Streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet 379, 547-556
  7. He Y, Cao L, Yu J (2018). Prophylactic lactoferrin for preventing late-onset sepsis and necrotizing entero-colitis in preterm infants: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore) 97, e11976
  8. Higgins RD, Saade G, Polin RA, et al (2016). Evaluation and management of women and newborns with a maternal diagnosis of chorioamnionitis: Summary of a workshop. Obstet Gynecol 127, 426-436
  9. Polin RA, Committee on Fetus and Newborn (2012). Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics 129, 1006-1015
  10. Randis TM, Polin RA, Saade G (2017). Chorioamnionitis: time for a new approach. Curr Opin Pediatr 29, 159-164
  11. Thatrimontrichai A (2014a). Best practice of neonatal care in Canada. Songkla Med J 32, 55-62
  12. Thatrimontrichai A (2014b). Care of preterm infant in Canada. Songkla Med J 32, 117-128
  13. Thatrimontrichai A (2017). Gut microbiota and probiotics in neonate. Songkla Med J 35, 101-108
  14. Thatrimontrichai A, Apisarnthanarak A, Chanvitan P, et al (2013). Risk factors and outcomes of carbapenem-resistant Acinetobacter baumannii bacteremia in neonatal intensive care unit: a case-case-control study. Pediatr Infect Dis J 32, 140-145
  15. Thatrimontrichai A, Chanvitan P, Janjindamai W, et al (2014). Trends in neonatal sepsis in a neonatal intensive care unit in Thailand before and after construction of a new facility. Asian Biomed 8, 771-778
  16. Thatrimontrichai A, Khunnarakpong N, Tantichantha-karun P, et al (2017a). Neonatal group B Streptoco-ccus sepsis: a multicenter study in Thailand. Southeast Asian J Trop Med Public Health 48, 1063-1071
  17. Thatrimontrichai A, Khunnarakpong N, Techato C, et al (2018a). Neonatal Listeriosis with emphasis on Thailand, 1991-2016. Southeast Asian J Trop Med Public Health 49, 826-834
  18. Thatrimontrichai A, Kittivisuit S, Janjindamai W, et al (2018b). Trend and cut-off point of neonatal meningitis onset in a highly multidrug-resistant area. Southeast Asian J Trop Med Public Health 49, 438-446
  19. Thatrimontrichai A, Rujeerapaiboon N, Janjindamai W, et al (2017b). Outcomes and risk factors of ventilator-associated pneumonia in neonates. World J Pediatr 13, 328-334
  20. Thatrimontrichai A, Techato C, Dissaneevate S, et al (2016). Risk factors and outcomes of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia in the neonate: a case-case-control study. J Infect Chemother 22, 444-449
  21. The Centers for Disease Control and Prevention (CDC) and National Healthcare Safety Network (NHSN). (2018). Bloodstream infection event (central line-associated bloodstream infection and non-central line-associated bloodstream infection). Retrieved 31 Jan, 2018, from http://www.cdc.gov/nhsn/pdfs/pscmanual/ 4psc_clabscurrent.pdf
  22. Verani JR, McGee L, Schrag SJ, et al (2010). Prevention of perinatal group B Streptococcal disease--revised guidelines from CDC, 2010. MMWR Recomm Rep 59, 1-36
  23. Villamor-Martinez E, Pierro M, Cavallaro G, et al (2018). Donor human milk protects against broncho-pulmonary dysplasia: a systematic review and meta-analysis. Nutrients 10